These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29498523)

  • 1. Glass-Transition Temperature of the β-Relaxation as the Major Predictive Parameter for Recrystallization of Neat Amorphous Drugs.
    Kissi EO; Grohganz H; Löbmann K; Ruggiero MT; Zeitler JA; Rades T
    J Phys Chem B; 2018 Mar; 122(10):2803-2808. PubMed ID: 29498523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations.
    Kissi EO; Kasten G; Löbmann K; Rades T; Grohganz H
    Mol Pharm; 2018 Sep; 15(9):4247-4256. PubMed ID: 30020794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs.
    Kissi EO; Ruggiero MT; Hempel NJ; Song Z; Grohganz H; Rades T; Löbmann K
    Phys Chem Chem Phys; 2019 Sep; 21(35):19686-19694. PubMed ID: 31469369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
    Bhugra C; Shmeis R; Krill SL; Pikal MJ
    Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
    Luebbert C; Huxoll F; Sadowski G
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of Caged Molecule Dynamics to JG β-Relaxation II: Polymers.
    Ngai KL; Capaccioli S; Prevosto D; Wang LM
    J Phys Chem B; 2015 Sep; 119(38):12502-18. PubMed ID: 26317769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
    Shete G; Khomane KS; Bansal AK
    J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glass transition and enthalpy relaxation of amorphous lactose glass.
    Haque MK; Kawai K; Suzuki T
    Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the solubility enhancement of amorphous drugs and related phenomena using basic thermodynamic principles and semi-empirical kinetic models.
    Skrdla PJ; Floyd PD; Dell'Orco PC
    Int J Pharm; 2019 Aug; 567():118465. PubMed ID: 31279056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of water and trehalose on α- and β-relaxation of freeze-dried lysozyme formulations.
    Vallaster B; Engelsing F; Grohganz H
    Eur J Pharm Biopharm; 2024 Jan; 194():1-8. PubMed ID: 38029940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation.
    Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
    Mol Pharm; 2016 Sep; 13(9):3318-25. PubMed ID: 27529364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.